Campo P, Soto Campos G, Moreira A, Quirce S, et al. Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment. Allergy 2020 Nov 21. doi: 10.1111/all.14668.
PMID: 33220106